Form: 10-Q/A

Quarterly report pursuant to Section 13 or 15(d)

February 17, 2011

Documents

EXHIBIT 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Amendment No. 1 to Quarterly Report of NeoGenomics, Inc. (the “Company”) on Form 10-Q/A for the three months ended June 30, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned, in the capacities and on the dates indicated below, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Date: February 17, 2011   
 
 /s/ Douglas M. VanOort  
   
Douglas M. VanOort
  
   
Chairman and Chief Executive Officer
 
       
Date: February 17, 2011   
/s/ George Cardoza
  
    George Cardoza  
   
Chief Financial Officer
  
       
Date: February 17, 2011   
/s/ Jerome J. Dvonch
  
   
Jerome J. Dvonch
  
    Director of Finance and Principal Accounting Officer  
 
The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. § 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.